# EDGAR Filing Document

**Accession Number:** 0000868675
**File Stem:** 0001104659-25-120916
**Filing Date:** 2025-12
**Character Count:** 22247
**Document Hash:** 2c42618bf66318002b925f98fe1e3040
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-120916.hdr.sgml**: 20251215

**ACCESSION NUMBER**: 0001104659-25-120916

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20251215

**FILED AS OF DATE**: 20251215

**DATE AS OF CHANGE**: 20251215

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TELUS CORP
- **CENTRAL INDEX KEY:** 0000868675
- **STANDARD INDUSTRIAL CLASSIFICATION:** RADIO TELEPHONE COMMUNICATIONS [4812]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 980361292
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15144
- **FILM NUMBER:** 251570186

**BUSINESS ADDRESS:**
- **STREET 1:** 510 W. GEORGIA STREET
- **STREET 2:** 23RD FLOOR
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6B 0M3
- **BUSINESS PHONE:** 604-697-8044

**MAIL ADDRESS:**
- **STREET 1:** 510 W. GEORGIA STREET
- **STREET 2:** 23RD FLOOR
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6B 0M3

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**<br> **WASHINGTON, D.C. 20549**

**FORM 6-K**

**Report of Foreign Private Issuer<br> Pursuant to Rule 13a-16 or 15d-16<br> under the Securities Exchange Act of 1934**

**For the month of December 2025<br> Commission File Number 001-15144**

**TELUS CORPORATION**<br> (Translation of registrant's name into English)

**23rd Floor, 510 West Georgia Street<br> Vancouver, British Columbia V6B 0M3<br> Canada**<br> (Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ◻ Form 40-F ⌧

**Signatures**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| **TELUS CORPORATION** | **TELUS CORPORATION** | **TELUS CORPORATION** |
| By: | /s/ Andrea Wood | /s/ Andrea Wood |
|  | Name: | Andrea Wood |
|  | Title: | Executive Vice President and Chief Legal and Governance Officer |

---

Date: December 15, 2025

**Exhibit Index**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description of Document** |
| [99.1](tm2533465d1_ex99-1.htm) | [Press Release dated December 12, 2025](tm2533465d1_ex99-1.htm) |
| [99.2](tm2533465d1_ex99-2.htm) | [Press Release dated December 15, 2025](tm2533465d1_ex99-2.htm) |

---

## Exhibit 99.1

**Exhibit 99.1**

 **News Release**

December 12, 2025

**TELUS Announces Pricing of Cash Tender Offers for Seven Series of Debt Securities**

**Vancouver, B.C.** – TELUS Corporation ("**TELUS**" or "the "**Company**") announced today the pricing terms of its previously announced separate offers (the "**Offers**") to purchase for cash up to the Maximum Purchase Amount (as defined in the Offer to Purchase dated December 4, 2025 (the "**Offer to Purchase**"), as previously amended) of its outstanding notes of the series listed in the table below (collectively, the "**Notes**").

**The Offers**

The Offers were made upon the terms and subject to the conditions set forth in the Offer to Purchase relating to the Notes. Capitalized terms used but not defined in this news release have the meanings given to them in the Offer to Purchase.

The table below sets out the aggregate principal amount of Notes accepted for purchase, the Reference Yield and the Total Consideration in respect of the Notes validly tendered and accepted for purchase pursuant to the Offers for such Notes.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Title of<br> Notes<sup>(1)</sup>** | &nbsp;&nbsp;**Principal<br> Amount<br> Outstanding**  | &nbsp;&nbsp;**CUSIP / ISIN<br> Nos.<sup>(1)</sup>** | &nbsp;&nbsp;**Reference<br> Security** | &nbsp;&nbsp;**Bloomberg<br> Reference<br> Page** | &nbsp;&nbsp;**Reference<br> Yield<sup>(2)</sup>** | &nbsp;&nbsp;**Fixed<br> Spread<br> (Basis<br> Points)<sup>(2)</sup>** | &nbsp;&nbsp;**Total<br> Consideration<sup>(3)</sup>** | &nbsp;&nbsp;**Principal<br> Amount<br> Accepted** |
| &nbsp;&nbsp;3.95% Notes, Series CAB due February, 2050 | &nbsp;&nbsp;C$105,257,000 | &nbsp;&nbsp;87971MBP7 / CA87971MBP73 | &nbsp;&nbsp; CAN 2¾<br> 12/01/55 | &nbsp;&nbsp; FIT<br> CAN0-50 | &nbsp;&nbsp;3.886% | &nbsp;&nbsp;+145 | &nbsp;&nbsp;C$812.94 | &nbsp;&nbsp;C$31,933,000 |
| &nbsp;&nbsp;4.10% Notes, Series CAE due April, 2051 | &nbsp;&nbsp;C$78,105,000 | &nbsp;&nbsp;87971MBT9 / CA87971MBT95 | &nbsp;&nbsp; CAN 2¾<br> 12/01/55 | &nbsp;&nbsp; FIT<br> CAN0-50 | &nbsp;&nbsp;3.886% | &nbsp;&nbsp;+145 | &nbsp;&nbsp;C$829.41 | &nbsp;&nbsp;C$28,867,000 |
| &nbsp;&nbsp;4.40% Notes, Series CU due January, 2046 | &nbsp;&nbsp;C$233,187,000 | &nbsp;&nbsp;87971MBB8 / CA87971MBB87 | &nbsp;&nbsp; CAN 2¾<br> 12/01/55 | &nbsp;&nbsp; FIT<br> CAN0-50 | &nbsp;&nbsp;3.886% | &nbsp;&nbsp;+135 | &nbsp;&nbsp;C$896.72 | &nbsp;&nbsp;C$173,548,000 |
| &nbsp;&nbsp;4.40% Notes, Series CL due April, 2043 | &nbsp;&nbsp;C$600,000,000 | &nbsp;&nbsp;87971MAS2 / CA87971MAS22 | &nbsp;&nbsp; CAN 2¾<br> 12/01/55 | &nbsp;&nbsp; FIT<br> CAN0-50 | &nbsp;&nbsp;3.886% | &nbsp;&nbsp;+125 | &nbsp;&nbsp;C$916.26 | &nbsp;&nbsp;C$471,132,000 |
| &nbsp;&nbsp;4.70% Notes, Series CW due March, 2048 | &nbsp;&nbsp;C$475,000,000 | &nbsp;&nbsp;87971MBE2 / CA87971MBE27 | &nbsp;&nbsp; CAN 2¾<br> 12/01/55 | &nbsp;&nbsp; FIT<br> CAN0-50 | &nbsp;&nbsp;3.886% | &nbsp;&nbsp;+130 | &nbsp;&nbsp;C$936.25 | &nbsp;&nbsp;C$386,386,000 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Title of<br> Notes<sup>(1)</sup>** | &nbsp;&nbsp;**Principal<br> Amount<br> Outstanding**  | &nbsp;&nbsp;**CUSIP / ISIN<br> Nos.<sup>(1)</sup>** | &nbsp;&nbsp;**Reference<br> Security** | &nbsp;&nbsp;**Bloomberg<br> Reference<br> Page** | &nbsp;&nbsp;**Reference<br> Yield<sup>(2)</sup>** | &nbsp;&nbsp;**Fixed<br> Spread<br> (Basis<br> Points)<sup>(2)</sup>** | &nbsp;&nbsp;**Total<br> Consideration<sup>(3)</sup>** | &nbsp;&nbsp;**Principal<br> Amount<br> Accepted** |
| &nbsp;&nbsp;2.85% Notes, Series CAF due November, 2031 | &nbsp;&nbsp;C$750,000,000 | &nbsp;&nbsp;87971MBV4 / CA87971MBV42 | &nbsp;&nbsp; CAN 1½<br> 06/01/31 | &nbsp;&nbsp; FIT<br> CAN0-50 | &nbsp;&nbsp;- | &nbsp;&nbsp;+60 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;4.75% Notes, Series CR due January, 2045 | &nbsp;&nbsp;C$400,000,000 | &nbsp;&nbsp;87971MAY9 / CA87971MAY99 | &nbsp;&nbsp; CAN 2¾<br> 12/01/55 | &nbsp;&nbsp; FIT<br> CAN0-50 | &nbsp;&nbsp;- | &nbsp;&nbsp;+130 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |

---

(1) No representation is made by the Company as to the correctness
or accuracy of the CUSIP number or ISIN listed in this news release or printed on the Notes. They are provided solely for convenience.

(2) Reference Yield refers to the yield based on the bid-side price
of the applicable Reference Security as specified in the table above, as quoted on the applicable Bloomberg Reference Page as of
11:00 a.m. (Eastern time) on December 12, 2025. The sum of the Reference Yield and the Fixed Spread is referred to as the "Offer
Yield".

(3) Per C$1,000 principal amount of Notes validly tendered, and not validly withdrawn, at or prior to December 11, 2025 (the "**Expiration Date**") and accepted for purchase; excludes the Accrued Coupon Payment.

The Financing Condition as described in the Offer to Purchase has been satisfied as a result of the closing of the Company's previously announced concurrent offerings of Canadian and U.S. junior subordinated notes in aggregate principal amounts of CAD$800 million and US$1.5 billion, respectively.

**Settlement**

Payment of the Total Consideration for the Notes accepted for purchase will be made by the Company on the "Settlement Date", which is expected to occur on December 16, 2025 (the "**Settlement Date**"). In addition to the Total Consideration, Holders whose Notes are accepted for purchase will receive a cash payment equal to the Accrued Coupon Payment, representing accrued and unpaid interest on such Notes from and including the immediately preceding interest payment date for such Notes to, but excluding, the Settlement Date. Holders whose Notes are accepted for purchase will lose all rights as a Holder of the tendered Notes and interest will cease to accrue on the Settlement Date for all Notes accepted in the Offer.

Following consummation of an Offer, any Notes that are purchased in such Offer will be retired and cancelled and no longer remain outstanding. All Notes not accepted for purchase by the Company will be returned without cost to the tendering Holders.

The Company has retained CIBC World Markets Inc. ("**CIBC**"), BMO Nesbitt Burns Inc. ("**BMO**"), RBC Dominion Securities Inc. ("**RBC**"), Scotia Capital Inc. ("**Scotia**") and TD Securities Inc. ("**TD**") to act as lead dealer managers and Desjardins Securities Inc., National Bank Financial Inc., Wells Fargo Securities Canada, Ltd., BNP Paribas (Canada) Securities Inc., SMBC Nikko Securities Canada, Ltd. and ATB Securities Inc. to act as co-dealer managers (collectively, the "**Dealer Managers**") for the Offers. Questions regarding the terms and conditions for the Offers or for copies of the Offer to Purchase should be directed to CIBC at 1-416-594-8515 (collect), BMO at 1-833-418-0762 (toll-free) or 1-416-359-6359 (collect), RBC at 1-877-381-2099 (toll-free) or 1-416-842-6311 (collect), Scotia at 1-416-863-7438 (collect) or TD at 1-866-584-2096 (toll-free) or 1-416-982-6451 (collect). You may also contact your broker, dealer, commercial bank, trust company or other nominee for assistance concerning the Offers.

Computershare Investor Services Inc. is acting as Tender Agent for the Offers.

If the Company terminates any Offer with respect to one or more series of Notes, it will give prompt notice to the Tender Agent, and all Notes tendered pursuant to such terminated Offer will be returned promptly to the tendering Holders thereof. With effect from such termination, any Notes blocked in CDS will be released.

**Offer and Distribution Restrictions**

The Offers were made solely pursuant to the Offer to Purchase. This news release does not constitute a solicitation of an offer to buy any securities in the United States. No Offer constitutes an offer or an invitation by, or on behalf of, TELUS or the Dealer Managers (i) to participate in the Offers in the United States; (ii) to, or for the account or benefit of, any "U.S. person" (as such term is defined in Regulation S of the U.S. Securities Act of 1933, as amended); or (iii) to participate in the Offers in any jurisdiction in which it is unlawful to make such an offer or solicitation in such jurisdiction, and such persons are not eligible to participate in or tender any securities pursuant to the Offers. No action has been or will be taken in the United States or any other jurisdiction that would permit the possession, circulation or distribution of this news release, the Offer to Purchase or any other offering material or advertisements in connection with the Offers to (i) any person in the United States; (ii) any U.S. person; (iii) anyone in any other jurisdiction in which such offer or solicitation is not authorized; or (iv) any person to whom it is unlawful to make such offer or solicitation. Accordingly, neither this news release, the Offer to Purchase nor any other offering material or advertisements in connection with the Offers may be distributed or published, in or from the United States or any such other jurisdiction (except in compliance with any applicable rules or regulations of such other jurisdiction). Tenders will not be accepted from any Holder located or resident in the United States.

In any jurisdiction in which the securities laws require the Offers to be made by a licensed broker or dealer, the Offers will be deemed to have been made on behalf of the Company by the Dealer Managers or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction.

This news release is for informational purposes only. This news release is not an offer to purchase or a solicitation of an offer to sell any Notes or any other securities of TELUS or any of its subsidiaries.

**Forward-looking Statements**

This news release contains statements about future events, including statements regarding the terms and timing for completion of the Offers, including the expected Settlement Date. By their nature, forward-looking statements require us to make assumptions and predictions and are subject to inherent risks and uncertainties including risks associated with capital and debt markets. There is significant risk that the forward-looking statements will not prove to be accurate. Forward-looking statements are provided herein for the purpose of giving information about the Offers referred to above. Readers are cautioned that such information may not be appropriate for other purposes. Readers are cautioned not to place undue reliance on forward-looking statements as a number of factors could cause actual future performance and events to differ materially from those described in the forward-looking statements. Accordingly, this news release is subject to the disclaimer and the qualifications and risk factors as set out in our 2024 annual management's discussion and analysis and in our third quarter 2025 management's discussion and analysis and other TELUS public disclosure documents and filings with securities commissions in Canada (on SEDAR+ at sedarplus.ca) and in the United States (on EDGAR at sec.gov). The forward-looking statements contained in this news release describe our expectations at the date of this news release and, accordingly, are subject to change after such date. Except as required by law or the Offer to Purchase, TELUS disclaims any intention or obligation to update or revise forward-looking statements.

**About TELUS**

TELUS (TSX: T, NYSE: TU) is a world-leading communications technology company operating in more than 45 countries and generating over C$20 billion in annual revenue with more than 20 million customer connections through our advanced suite of broadband services for consumers, businesses and the public sector. We are committed to leveraging our technology to enable remarkable human outcomes. TELUS is passionate about putting our customers and communities first, leading the way globally in client service excellence and social capitalism. TELUS Health is enhancing more than 160 million lives across 200 countries and territories through innovative preventive medicine and well-being technologies. TELUS Agriculture & Consumer Goods utilizes digital technologies and data insights to optimize the connection between producers and consumers. TELUS Digital specializes in digital customer experiences and future-focused digital transformations that deliver value for their global clients. Guided by our enduring 'give where we live' philosophy, TELUS, our team members and retirees have contributed C$1.8 billion in cash, in-kind contributions, time and programs including 2.4 million days of service since 2000, earning us the distinction of the world's most giving company. For more information, visit <u>telus.com</u> or follow <u>@TELUSNews</u> on X and <u>@Darren_Entwistle</u> on Instagram.

**Investor Relations**<br> Robert Mitchell<br> <u>ir@telus.com</u>

**Media Relations**<br> Steve Beisswanger

<u>Steve.Beisswanger@telus.com</u>

## Exhibit 99.2

**Exhibit 99.2**

 **News Release**

December 15, 2025

**TELUS receives approval for normal course issuer bid**

**Vancouver, B.C. –** TELUS Corporation (TELUS) (TSX: T, NYSE: TU) has received approval from the Toronto Stock Exchange (the TSX) for a new normal course issuer bid (the 2025 NCIB) to purchase and cancel, when and if considered advisable, up to C$500 million in shares over the 12 months commencing on December 17, 2025.

The 2025 NCIB will permit the purchase of up to 28 million TELUS shares (approximately 1.81 per cent of its outstanding shares as at December 10, 2025) for an aggregate purchase price of up to C$500 million from December 17, 2025 to December 16, 2026 through the facilities of the TSX, the New York Stock Exchange (the NYSE) and alternative Canadian trading systems or as otherwise permitted by applicable securities laws. The maximum number of shares that can be purchased during the same trading day on the TSX is 1,130,071 shares (being 25 per cent of the average daily trading volume for the six months ended November 30, 2025, which was equal to 4,520,286 shares), subject to certain exceptions for block purchases. As of December 10, 2025, TELUS had 1,550,956,136 shares issued and outstanding. All shares purchased under the NCIB will be cancelled.

The Company has not purchased any of its shares in the past 12 months.

Shares purchased through the facilities of the TSX, NYSE or alternative Canadian trading systems will be purchased at market price. TELUS may also purchase shares privately pursuant to exemption orders from applicable securities regulatory authorities, and such purchases will generally be at a discount to the prevailing market price.

TELUS may enter into automatic share purchase plans (ASPP) with a broker to permit TELUS to purchase shares under its 2025 NCIB during internal blackout periods. Such purchases would be at the discretion of the broker based on prearranged parameters. Subject to TSX approval, the ASPP may be implemented from time to time during the course of the 2025 NCIB thereafter.

TELUS' Board of Directors believes that any purchases made under the 2025 NCIB will be in the best interest of TELUS and that such purchases will constitute an attractive investment opportunity that should enhance the value of the remaining shares.

**Forward-Looking Statements**

This news release contains forward-looking information and statements about future events and plans at TELUS. Forward-looking information includes any statements that do not refer to historical facts. The use of any of the words "anticipate", "can", "could", "may", "should", "will", "would" and similar expressions, (including negatives thereof) are intended to identify forward-looking statements. In particular, this news release includes, without limitation, forward-looking statements pertaining to the creation of and the anticipated benefits of the 2025 NCIB; the potential implementation of an ASPP with a broker; and the number of shares, if any, that will be ultimately acquired by TELUS under its 2025 NCIB.

By their nature, forward-looking statements are subject to inherent risks and uncertainties including, but not limited to, the competitive environment, economic performance in Canada, TELUS' earnings and free cash flow and TELUS' levels of capital, all of which may affect the TELUS' ability or decision to purchase shares under its 2025 NCIB and are based on assumptions, including assumptions about future economic conditions and courses of action. These assumptions may ultimately prove to have been inaccurate and, as a result, actual results or events may differ materially from expectations expressed in or implied by the forward-looking statements.

The risks and the assumptions underlying the forward-looking statements are described in additional detail in *Section 9 General trends, outlook and assumptions, and regulatory developments and proceedings* and *Section 10 Risks and risk management* in TELUS' 2024 annual MD&A, as supplemented by *Section 9 Update to general trends, outlook and assumptions, and regulatory developments and proceedings* in TELUS' interim management's discussion & analysis for the third quarter ended September 30, 2025 and in other TELUS public disclosure documents and filings with securities commissions in Canada (on SEDAR+ at <u>www.sedarplus.ca</u>) and in the United States (on EDGAR at <u>www.sec.gov</u>). Those descriptions are incorporated by reference in this cautionary statement but are not intended to be a complete list of the risks that could affect TELUS or of the assumptions of TELUS.

Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this news release describe TELUS' expectations, and are based on their respective assumptions, as at the date of this news release and are subject to change after this date. TELUS disclaim any intention or obligation to update or revise any forward-looking statements except as required by law.

This cautionary statement qualifies all of the forward-looking statements in this news release.

**About TELUS**

TELUS is a world-leading communications technology company operating in more than 45 countries and generating over $20 billion in annual revenue with more than 20 million customer connections through our advanced suite of broadband services for consumers, businesses and the public sector. We are committed to leveraging our technology to enable remarkable human outcomes. TELUS is passionate about putting our customers and communities first, leading the way globally in client service excellence and social capitalism. TELUS Health is enhancing more than 160 million lives across 200 countries and territories through innovative preventive medicine and well-being technologies. TELUS Agriculture & Consumer Goods utilizes digital technologies and data insights to optimize the connection between producers and consumers. TELUS Digital specializes in digital customer experiences and future- focused digital transformations that deliver value for their global clients. Guided by our enduring 'give where we live' philosophy, TELUS, our team members and retirees have contributed $1.8 billion in cash, in-kind contributions, time and programs including 2.4 million days of service since 2000, earning us the distinction of the world's most giving company.

For more information, visit <u>telus.com</u> or follow <u>@TELUSNews</u> on X and <u>@Darren_Entwistle</u> on Instagram.

**Investor Relations**

Robert Mitchell

<u>ir@telus.com</u>

**Media Relations**

Steve Beisswanger

<u>Steve.Beisswanger@telus.com</u>